Abstract
Schistosomiasis is a chronic disease that infects an estimated 200 million persons, leading to an estimated 800,000 to 1 million annual deaths. It ranks second only to malaria in terms of morbidity and mortality caused by a parasitic disease. In addition, there is increasing evidence that schistosome infection may have profound effects on growth in children (de Lima e Costa et al., 1988; Corbett et al., 1992; McGarvey et al., 1993). Three species of schistosomes account for the vast majority of human infection: Schistosoma mansoni, found in South America, the Caribbean, Africa, and the Middle East; S. haematobium, found in Africa and the Middle East; and S. japonica, found in Asia and Southeast Asia. In addition, there are other species of schistosomes that infect humans with varying degrees of success such as S. intercalatum and S. mekongi. Disease is caused by the host immune response to parasite eggs that become trapped in tissues, forming granulomas. Granulomatous responses then lead to the development of fibrotic lesions, which in turn lead to portal hypertension, shunting, and esophageal varices. One or more of these serious disease manifestations are found in S. japonicum- and mansoni-infected patients who have developed hepatosplenic disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amory Soisson, L. M., Masterson, C. P., Tom, T. D., McNally, M. T., Lowell, G. H., and Strand, M., 1992, Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen, J. Immunol. 149:3612.
Balloul, J. M., Sondermeyer, P., Dreyer, D., Capron, M., Grzych, J. M., Pierce, R. J., Carvalho, D., Lecocq, J. P., and Capron, A., 1987, Molecular cloning of a protective antigen of schistosomes, Nature 326:149.
Boulanger, C., Reid, G. D. F., Sturrock, R. F., Wolowczuk, I., Balloul, J. M., Grezel, D., Pierce, R. J., Otieno, M. F., Guerret, S., Grimaud, J. A., Butterworth, A. E., and Capron, A., 1991, Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni, Parasite Immunol. 13:473.
Butterworth, A.E., Capron, M., Cordingley, J.S., Dalton, P.R., Dunne, D.W., Kariuki, H. C., Kimani, G., Koech, D., Mugambi, M., Ouma, J. H., Prentice, M. A., Richardson, B. A., Arap Siongok, T. K., Sturrock, R. F., and Taylor, D. W., 1985, Immunity after treatment of human Schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses, Trans. R. Soc. Trop. Med. Hyg. 79:393.
Butterworth, A. E., Dunne, D. W., Fulford, A., Capron, M., Khalife, J., Capron, A., Koech, D., Ouma, J. H., and Sturrock, R., 1988, Immunity in Schistosomiasis mansoni: Cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity, Biochemie 70:1053.
Chikunguwo, S. M., Kanazawa, T., Dayal, Y., and Stadecker, M. J., 1991, The cell mediated response to Schistosomiasis antigens at the clonal level: In vivo functions of cloned murine egg antigen-specific CD4+ T helper type 1 lymphocytes, 7. Immunol. 147:3921.
Chikunguwo, S. M., Quinn, J. J., Harn, D. A., and Stadecker, M. J., 1993, The cell mediated response to schistosomal antigens at the clonal level. III. Identification of soluble egg antigens recognized by cloned specific granulomagenic murine CD4+ Th1-type lymphocytes, J. Immunol. 150:1413.
Corbett, E. L., Butterworth, A. E., Fulford, A. J. C., Ouma, J. H., and Sturrock, R. F., 1992, Nutritional status of children with Schistosomiasis mansoni in two different areas of Machakos District, Kenya, Trans. R. Soc. Trop. Med. Hyg. 86:266.
Dalton, J. P., and Strand, M., 1987, Schistosoma mansoni Polypeptides immunogenic in mice vaccinated with radiation-attenuated cercariae, J. Immunol. 139:2474.
de Lima e Costa, M. M. F., Leite, M. L. C., Rocha, R. S., de Almeida, M. H., Magalhaes, H., and Katz, N., 1988, Anthropometric measures in relation to Schistosomiasis mansoni and socioeconomic variables, Int. J. Epidemiol. 17:880.
Dessein, A. J., Begley, M., Demeure, C., Caillol, D., Fueri, J., dos Reis, M. G., Andrade, Z. A., Prata. A., and Bina, J. C., 1988, Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kD larval surface antigen, J. Immunol. 140:2727.
Doenhoff, M., and Long, E., 1979, Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. IV. The inability of T-cell deprived mice to resist re-infection, and other in vivo studies on the mechanism of resistance, Parasitology 78:171.
Ford, M. J., Bickle, Q. D., Taylor, M. G., and Andrews, B. J., 1984, Passive transfer of resistance and the site of immune-dependent elimination of the challenge infection in rats vaccinated with highly irradiated cercariae of Schistosoma mansoni, Parasitology 89:461.
Hagan, P., Blumenthal, U. J., Dunne, D., Simpson, A. J. G., and Wilkins, H. A., 1991, Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium, Nature 349:243.
Harn, D. A., Mitsuyama, M., Huguenel, E. D., Oligino, L. D., and David, J. R., 1985a, Identification by monoclonal antibody of a major (28kDa) surface membrane antigen of Schistosoma mansoni, Mol. Biochem. Parasitol. 16:345.
Harn, D. A., Mitsuyama, M., Huguenel, E. D., and David, J. R., 1985b, Schistosoma mansoni: Detection by monoclonal antibody of a 22,000 dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites, J. Immunol. 135:2115.
Harn, D. A., Quinn, J. J., Oligino, L. D., Percy, A., Ko, A., Pham, K., Gross, A., Gebremichael, A., and Stein, L., 1987, Candidate epitopes for vaccination against Schistosomiasis mansoni, in: Molecular Paradigms for Eradicating Helminthic Parasitesi (A. J. Maclnnis, ed.), Liss, New York.
Harn, D. A., Gu, W., Oligino, L. D., Mitsuyama, M., Gebremichael, A., and Richter, D., 1992, A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triosephosphate isomerase, J. Immunol. 148:562.
Hsu, S., Li, Y., Hsu, F., and Burmeister, L.F., 1981, Schistosoma mansoni: Vaccination of mice with highly x-irradiated cercariae, Exp. Parasitol. 52:91.
James, S. L., 1987, Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. V. Effects of varying the immunization schedule and site, Parasite Immunol. 9:531.
Jwo, J., and LoVerde, P. T., 1989, The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice, J. Parasitol. 75:252.
Lanar, D. E., Pearce, E. J., James, S. L., and Sher, A., 1986, Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice, Science 234:593.
McGarvey, S. T., Wu, G., Zhang, S., Wang, Y., Peters, P., Olds, G. D., and Wiest, P. M., 1993, Child growth, nutritional status, and Schistosomiasis japonica in Jiangxi, Peoples Republic of China, Am. J. Trop. Med. Hyg. 48:547.
Mangold, B. L., and Dean, D. A., 1984, The migration and survival of gamma-irradiated Schistosoma mansoni larvae and the duration of host-parasite contact in relation to the induction of resistance in mice, Parasitology 88:249.
Mangold, B. L., and Dean, D. A., 1986, Passive transfer with serum and IgG antibodies of irradiated cercariae-induced resistance against Schistosoma mansoni in mice, J. Immunol. 136:2644.
Marguerite, M., Bosus, M., Mazingue, C., Wolowczuk, I., Gras-Masse, H., Tartar, A., Capron, A., and Auriault, C., 1992, Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide, Mol. Immunol. 29:793.
Oligino, L.D., Percy, A.J., and Harn, D.A., 1988, Purification and immunochemical characterization of a 22 kilodalton surface antigen from Schistosoma mansoni, Mol. Biochem. Parasitol. 28:95.
Pattaroyo, M.E., Romero, P., Torres, M.L., Clavijo, P., Moreno, A., Martinez, A., Rodriguez, R., Guzman, F., and Cabazas, E., 1987, Induction of protective immunity against experimental infection with malaria using synthetic peptides, Nature 328:629.
Pearce, E. J., James, S. L., Heiny, S., Lanar, D. E., and Sher, A., 1988, Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen, Proc. Natl. Acad. Sci. USA 85:5678.
Ramirez, B., 1993, TDRU Meeting on Control of Schistosomiasis, November, Manila.
Reynolds, S. R., and Harn, D. A., 1992, Comparison of irradiated-cercariae schistosome vaccine models that use 15-and 50-kilorad doses: The 15-kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge, Infect. Immun. 60:90.
Reynolds, S. R., Shoemaker, C. B., and Harn, D. A., 1992, T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni, J. Immunol. 149:3995.
Reynolds, S. R., Dahl, C. E., and Harn, D. A., 1994, T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase, J. Immunol. 152:193.
Reynolds, S. R., Jacobs, W. R., Cirillo, J. D., Kastens, W. A., Incani, R. N., Edwards, C. S., and Harn, D. A., 1995, Expression of immunologically and enzymatically active Schistosoma mansoni triose phosphate isomerase in BCG, (in press).
Richter, D., Incani, R. N., and Harn, D. A., 1993, Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni, Infect. Immun. 61:3003.
Rihet, P., Demeure, C. E., Bourgois, A., Prata, A., and Dessein, A. J., 1991, Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels, Eur. J. Immunol. 21:2679.
Rihet, P., Demeure, C. E., Dessein, A. J., and Bourgois, A., 1992, Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemicarea, Eur. J. Immunol. 22:2063.
Sher, A., Heiny, S., James, S.L., and Asofsky, R., 1982, Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement, J. Immunol. 128:1880.
Shoemaker, C., Gross, A., Gebremichael, A., and Harn, D. A., 1992, cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase, Proc. Natl. Acad. Sci. USA 89:1842.
Tarn, J. P., Clavijo, P., Lu, Y.-A., Nussenzweig, V., Nussenzweig, R., and Zavala, F., 1990, Incorporation of T and B cell epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria, J. Exp. Med. 171:299.
Wright, M. D., Henkle, K. J., and Mitchell, G. F., 1990, An immunogenic Mr 23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen, J. Immunol. 144:3195.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harn, D.A., Reynolds, S.R., Chikunguwo, S., Furlong, S., Dahl, C. (1995). Synthetic Peptide Vaccines for Schistosomiasis. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_40
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1823-5_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5737-7
Online ISBN: 978-1-4615-1823-5
eBook Packages: Springer Book Archive